URGN financials
UroGen Pharma (URGN) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
URGN income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $109.79M | $97.34M | -$124.86M | -$153.49M | -3.19 |
| 2024 | $90.40M | $81.52M | -$96.78M | -$126.87M | -2.96 |
| 2023 | $82.71M | $73.35M | -$65.54M | -$102.24M | -3.55 |
| 2022 | $64.36M | $56.70M | -$79.04M | -$109.78M | -4.79 |
| 2021 | $48.04M | $42.88M | -$92.29M | -$110.82M | -4.96 |
| 2020 | $11.80M | $10.79M | -$126.74M | -$128.48M | -5.90 |
- URGN revenue was $109.79M in fiscal 2025, net income -$153.49M.
Updated 2026-11-02 23:14 UTC